<<

PEDIATRIC ACUTE FAILURE: PEARLS AND PRIORITIES

Ryan Himes, M.D. Section Head, Pediatric , , & Nutrition Medical Director, Pediatric Liver Transplant Program Ochsner Medical Center, New Orleans

GASTROENTEROLOGY, HEPATOLOGY, & NUTRITION GASTROENTEROLOGY, HEPATOLOGY, & NUTRITION DISCLOSURES

• No relevant conflicts-of-interest

• Discussion of off-label use: • Molecular Adsorbent Recirculating System

GASTROENTEROLOGY, HEPATOLOGY, & NUTRITION OBJECTIVES • List common causes of acute in children of different ages

• Explain the concept “balanced coagulopathy”

• Utilize N-acetyl cysteine for appropriate cases of

GASTROENTEROLOGY, HEPATOLOGY, & NUTRITION CASE STUDY: 2-MONTH-OLD MALE

• Unremarkable term delivery • Growing well on Similac • Developed -streaked stools • Assessed by his pediatrician milk protein suspected • Alimentum started, but he vomited every feed

GASTROENTEROLOGY, HEPATOLOGY, & NUTRITION CASE STUDY: 2-MONTH-OLD MALE

• Seen in the emergency center • Pyloric US normal • Passed a “PO challenge” and sent home • Grandmother introduces a concoction of boiled rice and sugar • worsens, prompting return EC visit • Abdominal US and UGI studies normal

GASTROENTEROLOGY, HEPATOLOGY, & NUTRITION CASE STUDY: 2-MONTH-OLD MALE

SODIUM [H] 143 AST 444 (H) COLOR URINE YELLOW CARBON DIOXIDE [LL] 12 ALT 206 (H) APPEARANCE URINE [A] CLOUDY GLUCOSE [LL] 47 Alkaline Phos 573 (H) GLUCOSE URINE [A] 3+ BUN [L] 5 GGT 57 BILIRUBIN URINE NEGATIVE CREATININE [H] 1.16 Albumin 3.2 KETONE URINE [A] 1+ Bili Unconjugated 0.0 SPEC GRAV URINE 1.022 WBC 13.52 Bili Conjugated 2.1 (H) BLOOD URINE [A] TRACE HGB 11.1 PH URINE 5.5 HCT 34.3 Ammonia 179 (HH) PROTEIN URINE [A] 4+ [H] 626 INR (HH) 8.3 UROBILINOGEN URINE <2.0 NITRITE URINE NEGATIVE PH BLOOD 7.12 LEUKO URINE NEGATIVE BICARBONATE 10 LACTATE [H] 10.2 RED SUB URINE [A] 3+

GASTROENTEROLOGY, HEPATOLOGY, & NUTRITION DDX FOR ALF IN A 2-MONTH-OLD

• Infection/ (vomiting, 100.7 in EC) • FAO defect (1+ ketone with hypoglycemia) • Galactosemia • Tyrosinemia • Hereditary Fructose Intolerance • Storage disorders

GASTROENTEROLOGY, HEPATOLOGY, & NUTRITION Galactosemia Tyrosinemia HFI Incidence 1:63,000 1:100,000 1:20,000 Age Neonate Infant, child Infant, child V/D/lethargy X X X Hypoglycemia X X X Acidosis X X X Anemia Hemolytic Non-hemolytic Phos/Mg/Rickets X X Renal Fanconi Fanconi Fanconi

GASTROENTEROLOGY, HEPATOLOGY, & NUTRITION Common Infant Formulas Carbohydrate Source

Enfamil, Gerber, Similac Lactose, rice starch, maltodextrin

Nutramigen Corn syrup solids, cornstarch Corn syrup solids, dextrose, Pregestimil cornstarch Alimentum Sucrose, tapioca starch

Elecare, Neocate, Nutramigen AA Corn syrup solids

ALDOB sequence: p.R60X & p.A150P

GASTROENTEROLOGY, HEPATOLOGY, & NUTRITION AST

ALT

GASTROENTEROLOGY, HEPATOLOGY, & NUTRITION INR

GASTROENTEROLOGY, HEPATOLOGY, & NUTRITION PALF: Background, Natural History, & Etiology

GASTROENTEROLOGY, HEPATOLOGY, & NUTRITION DEFINITION OF PEDIATRIC ACUTE LIVER FAILURE

Sudden onset of… 1. Biochemical evidence of liver injury 2. Vitamin K-resistant coagulopathy . INR > 2 . INR 1.5-1.9, if encephalopathy is present 3. In an individual with no underlying

Pediatric Acute Liver Failure Study Group GASTROENTEROLOGY, HEPATOLOGY, & NUTRITION PALF EPIDEMIOLOGY

• Uncommon; ? 100-200 cases/year • No age, sex, racial, ethnic predilection • Weak signal for seasonality (Dec-Feb > Jun-Aug) • Accounts for 10-15% of pediatric LTs performed in the US annually (~50-75) • 15-20% of patients with PALF die awaiting LT

GASTROENTEROLOGY, HEPATOLOGY, & NUTRITION NATURAL HISTORY

Alive Liver Function Liver

Prodrome Dead Time  GASTROENTEROLOGY, HEPATOLOGY, & NUTRITION

Adapted from Liver Disease in Children, Suchy, Sokol, & Ballistreri ETIOLOGY • PALF represents the final common pathway for a diverse set of conditions • Direct injury • Host response • 33%-67% of PALF is indeterminate in etiology • Age of the patient is the most important factor in developing an initial differential diagnosis

GASTROENTEROLOGY, HEPATOLOGY, & NUTRITION INFANT/NEONATAL ALF <4 weeks 4-8 weeks 9 weeks-1 year Indeterminate 38% 41% 45% Acetaminophen 0 5% 5% Metabolic 16% 27% 20% Autoimmune 0 0 6% Viral 22% 0 4% Shock 4% 9% 6% GALD 14% 14% 1% HLH 1% 0 6%

GASTROENTEROLOGY, HEPATOLOGY, & NUTRITION

Pediatric Acute Liver Failure Study Group CHILD/ADOLESCENT ALF 1-5 years 6-10 years >10 years Indeterminate 67% 62% 32% Acetaminophen 4% 3% 29% Metabolic 5% 8% 9% Autoimmune 7% 5% 10% Viral 5% 3% 5% Shock 2% 7% 3% GALD 0 0 0 HLH 2% 0 0

GASTROENTEROLOGY, HEPATOLOGY, & NUTRITION

Pediatric Acute Liver Failure Study Group PALF: Practical Issues in Evaluation and Management

GASTROENTEROLOGY, HEPATOLOGY, & NUTRITION Initial Stabilization Discussion with LT center

Diagnostic Advanced ICU care Evaluation

GASTROENTEROLOGY, HEPATOLOGY, & NUTRITION DIAGNOSTIC EVALUATION A critically important initial priority is rapidly identifying a cause for PALF

Survival with native liver 94% acetaminophen 1. Identify treatable conditions 41% non-APAP drug 2. Informs prognosis 45% indeterminate 3. Aids in decision making vis-à-vis transplantation

GASTROENTEROLOGY, HEPATOLOGY, & NUTRITION EXCLUDE TREATABLE CONDITIONS

Entity Treatment Initial Test Galactosemia Exclude dietary lactose GALT activity Tyrosinemia Tyr & Phe exclusion, NTBC Urine succinylacetone Hereditary Fructose Intolerance Exclude dietary fructose & sucrose History Herpes Simplex Virus Acyclovir PCR Gestational Alloimmune Liver IVIG and exchange transfusion History, ferritin Disease Acetaminophen N-acetylcysteine Acetaminophen level Autoimmune Steroids Antibodies, total IgG

GASTROENTEROLOGY, HEPATOLOGY, & NUTRITION SPECIAL CONSIDERATIONS FOR POTENTIAL TRANSPLANT CANDIDATES • Advanced cardiopulmonary disease • Uncontrolled malignancy not confined to the liver • Mitochondrial disorders • Untreatable infection outside the liver •

GASTROENTEROLOGY, HEPATOLOGY, & NUTRITION DIAGNOSTIC EVALUATION

• Blood is precious-someone must be its steward 1. Labs needed for life support 2. High priority diagnostic tests 3. Routine priority diagnostic tests

• Liver biopsy?

GASTROENTEROLOGY, HEPATOLOGY, & NUTRITION LIVER BIOPSY: PRIMUM NON NOCERE

• Prognosis • Diagnosis • Often a short window to obtain • Balance risks of transport, sedation,

GASTROENTEROLOGY, HEPATOLOGY, & NUTRITION 12-YEAR-OLD FEMALE

GASTROENTEROLOGY, HEPATOLOGY, & NUTRITION

Courtesy Mihail Firan, MD EXPLANT - 8 DAYS LATER

GASTROENTEROLOGY, HEPATOLOGY, & NUTRITION

Courtesy Mihail Firan, MD ADVANCED ICU CARE

1. Coagulopathy

2. Hepatic Encephalopathy

3. N-acetylcysteine for non- acetaminophen PALF

GASTROENTEROLOGY, HEPATOLOGY, & NUTRITION

Bernal & Wendon, NEJM, 2013 (1) COAGULOPATHY

Goal: avoid bleeding complications & unnecessary administration of blood products • INR widely used to gauge liver synthetic function • May overestimate the degree of coagulopathy • Balanced reduction in hepatic synthesis of both procoagulant and proteins

GASTROENTEROLOGY, HEPATOLOGY, & NUTRITION Balanced coagulopathy of liver failure

GASTROENTEROLOGY, HEPATOLOGY, & NUTRITION

Trppodi & Mannucci, NEJM, 2011 5-year-old male with ALF INR 3.1, 422,000

GASTROENTEROLOGY, HEPATOLOGY, & NUTRITION COAGULOPATHY – TREATMENT

• Administer parenteral vitamin K • Avoid efforts to “correct” the INR or platelet count with blood products except where there is bleeding, or an invasive procedure is required • Obtain thromboelastography/ROTEM to evaluate the entire kinetics of hemostasis (pro-, anticoagulant factors, , platelets, red cells) • Plasmapheresis for unbalanced coagulopathy with bleeding

GASTROENTEROLOGY, HEPATOLOGY, & NUTRITION HEPATIC ENCEPHALOPATHY - MOLECULAR ADSORBENT RECIRCULATING SYSTEM • FDA cleared for acute poisoning and HE due to chronic liver disease in adults • Add-on to conventional CRRT circuit • Efficient removal of protein-bound molecules in addition to the clearance of water-soluble molecules in CRRT

GASTROENTEROLOGY, HEPATOLOGY, & NUTRITION Does not remove Removes • Albumin • Bilirubin • IgG • Bile acids • Clotting • Copper factors • Ammonia • Binding • Cytokines proteins • Nitric oxide

GASTROENTEROLOGY, HEPATOLOGY, & NUTRITION GASTROENTEROLOGY, HEPATOLOGY, & NUTRITION GASTROENTEROLOGY, HEPATOLOGY, & NUTRITION (3) N-ACETYLCYSTEINE FOR NON-APAP ALF

• Adult patients with non-APAP ALF • 81 = NAC, 92 = Placebo • Transplant-free survival 52% vs. 30% (p<0.05) • Benefit appears limited to early stage HE

GASTROENTEROLOGY, HEPATOLOGY, & NUTRITION • Children with non-APAP PALF • 92 = NAC, 92 = Placebo • 70% of both groups had HE grade 1-2

GASTROENTEROLOGY, HEPATOLOGY, & NUTRITION OBJECTIVES • List common causes of acute liver failure in children of different ages

• Explain the concept “balanced coagulopathy”

• Utilize N-acetyl cysteine for appropriate cases of acute liver failure

GASTROENTEROLOGY, HEPATOLOGY, & NUTRITION THANK YOU

Ryan Himes, MD [email protected] cell 713-882-0032

GASTROENTEROLOGY, HEPATOLOGY, & NUTRITION